Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

NSE:SUNPHARMA Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	113,316	92,857	46,237	45,083	62,730
Short-Term Investments	136,561	53,712	60,041	44,695	32,592
Trading Asset Securities	-	44,332	45,022	36,771	310
Cash & Short-Term Investments	249,877	190,901	151,300	126,548	95,632
Cash Growth	30.89%	26.17%	19.56%	32.33%	-12.58%
Accounts Receivable	130,461	112,602	114,568	105,035	90,979
Other Receivables	-	6,188	4,136	3,509	7,366
Receivables	130,945	119,440	119,117	110,243	98,905
Inventory	102,433	102,949	109,683	92,392	93,618
Prepaid Expenses	-	4,135	3,718	2,862	2,787
Other Current Assets	42,989	17,325	15,015	16,601	13,479
Total Current Assets	526,245	434,750	398,833	348,646	304,421
Property, Plant & Equipment	112,703	113,001	113,537	111,689	111,715
Long-Term Investments	46,977	64,412	54,517	49,592	64,824
Goodwill	89,394	85,990	83,580	65,913	62,876
Other Intangible Assets	90,205	86,663	93,268	61,918	56,607
Long-Term Accounts Receivable	-	-	108.3	193.7	305.5
Long-Term Deferred Tax Assets	44,076	41,037	35,189	28,496	35,564
Other Long-Term Assets	11,378	28,769	28,396	31,623	40,348
Total Assets	921,006	854,629	807,436	698,078	676,667
Accounts Payable	61,843	56,533	56,815	44,898	39,737
Accrued Expenses	-	16,889	15,127	14,833	11,972
Short-Term Debt	18,671	28,444	59,583	4,685	24,449
Current Portion of Long-Term Debt	-	-	2,396	2,323	4,239
Current Portion of Leases	1,368	1,257	1,281	1,078	1,017
Current Income Taxes Payable	7,332	4,117	3,087	1,756	1,791
Current Unearned Revenue	-	1,265	1,567	1,930	2,143
Other Current Liabilities	92,728	61,339	59,214	100,582	76,110
Total Current Liabilities	181,942	169,844	199,070	172,085	161,456
Long-Term Debt	25.2	13.3	-	2,299	6,547
Long-Term Leases	3,557	3,023	5,599	2,518	2,434
Long-Term Unearned Revenue	-	4,887	5,699	6,188	7,186
Long-Term Deferred Tax Liabilities	1,924	1,551	316.9	318.6	445.1
Other Long-Term Liabilities	8,697	253.7	334.6	575.4	914.6
Total Liabilities	196,146	183,569	214,281	187,417	181,869
Common Stock	2,399	2,399	2,399	2,399	2,399
Additional Paid-In Capital	-	11,874	11,874	11,874	11,874
Retained Earnings	-	537,452	472,009	412,363	401,887
Comprehensive Income & Other	719,781	84,942	73,671	53,476	48,467
Total Common Equity	722,180	636,668	559,954	480,112	464,628
Minority Interest	2,679	34,392	33,201	30,549	30,171
Shareholders' Equity	724,860	671,060	593,155	510,661	494,798
Total Liabilities & Equity	921,006	854,629	807,436	698,078	676,667
Total Debt	23,622	32,737	68,859	12,903	38,686
Net Cash (Debt)	226,255	158,164	82,441	113,645	56,946
Net Cash Growth	43.05%	91.85%	-27.46%	99.57%	116.94%
Net Cash Per Share	94.40	65.92	34.36	47.37	23.73
Filing Date Shares Outstanding	2,389	2,399	2,399	2,399	2,399
Total Common Shares Outstanding	2,389	2,399	2,399	2,399	2,399
Working Capital	344,303	264,906	199,763	176,562	142,965
Book Value Per Share	302.32	265.35	233.38	200.10	193.65
Tangible Book Value	542,581	464,015	383,105	352,282	345,145
Tangible Book Value Per Share	227.14	193.39	159.67	146.82	143.85
Land	-	8,173	6,676	6,448	4,426
Buildings	-	63,610	61,395	57,836	57,091
Machinery	-	146,265	139,645	132,031	124,281
Construction In Progress	-	11,077	9,634	7,975	9,365

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.